A specific combination of targeted therapy and immunotherapy may better help patients with non-small cell lung cancer (NSCLC) overcome inherent immune resistance and reinvigorate anti-tumor activity, according to a new study led by a researcher from The University of Texas MD Anderson Cancer Center.
Denial of Lykos’ MDMA-Assisted PTSD Therapy Followed by Retraction of Related Studies | Psychedelic Invest
A day after the regulatory rejection of Lykos Therapeutics’ MDMA-assisted therapy for PTSD, the scientific community faced another setback as a prominent medical journal retracted
August 12, 2024